Large Volume Parenteral Market continues to expand with growing surgical procedures and higher preference for single-dose administration of vaccines and drugs

 

Large Volume Parenteral (LVP) is the term given to plasma volume in a patient's bloodstream during a medical procedure. It can range from less than half a liter to more than one liter of plasma. This amount of plasma could come from a variety of different sources, including venous injections, coronary artery bypass grafts, and even stem cells taken from a patient's own bone marrow. With technological advancements, surgical procedures across the globe are increasing rapidly. These procedures have become significantly safer than before with high success rate. Naturally, the demand for large volume parenteral has increased for intravenous solutions. As per the Eurostat, in 2018, around 1.16 million cesarean sections were performed in the EU-27. As per the same source, in 2018, around 1656 cataract surgeries per 100,000 inhabitants were performed in Latvia. These stats suggest high demand for large volume parenteral, which could potentially boost growth of the large volume parenteral market.

Governments in the U.S. and Canada as well as private companies are increasingly investing significantly in research and development activities in the healthcare sector, medical devices, and biotechnology sector. This, in turn, is aiding in growth of the regional large volume parenteral market. Governments of these countries offer favorable reimbursement policies, which in turn, is increasing hospital admission. Such factors can augment growth of the Large Volume Parenteral Market.

There are four major components of large volume Parenteral that make up this process. They include venous insufficiency, intravenous fluid leak, central venous congestion, and peripheral vasoconstriction. Healthcare providers are increasingly preferring to single-dose administration of vaccines and drugs to treat chronic diseases. Single-dose vaccines help to mitigate adverse events such as chills, fatigue, and headaches, while they also help in reducing vaccine wastage. Such factors are stimulating growth of the large volume parenteral market.

Venous insufficiency refers to the lack of a sufficient amount of blood reaching a particular organ or part of the body. There can be many reasons for a patient having insufficient blood flow, which in many cases can be easily corrected. There are numerous challenges associated with the formulation of LVPs. One of the key challenges in the formulation of LVP is to achieve good compatibility of the drug substances with excipients as well as compatibility of the preparations with the primary container. Such factors could limit growth of the large volume parenteral market in the near future.